-
Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald
来源: Buzz FX / 07 11月 2024 07:56:17 America/New_York
Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) was upgraded by investment
Read more...